Welcome to Trisys Care Online Store!

logo
user join
Home
  • secondimagealt
  • thirdimage
  • fourthimage
main image

Sallaki Tablets

Gufic Bio

M.R.P: USD5.00
In Stock
Inaugural Offer Free Shipping

Delivery

Check for estimated delivery date

Description

Sallaki Tablets

Gufic Sallaki Tablets

Description:Gufic Sallaki 600/400 MG Tablet is a proprietary Ayurvedic medicine manufactured by Gufic Biosciences Limited. It is mainly used in the treatment of Osteoarthritis and Rheumatoid arthritis.

 Gufic Sallaki 600/400 MG Tablet Ingredients:

Each tablet contains

Salai Guggul – Boswellia serrata– 600/400 mg – It is a famous Ayurvedic herb used mainly for the treatment of osteo-arthritis and muscular pains.

 Gufic Sallaki 600/400 MG Tablet Indications:

  • Osteoarthritis
  • Rheumatoid arthritis
  • Myositis
  • Fibrositis
  • Musculoskeletal disorders.

Dosage: 1 tablet thrice a day for 8-12 weeks.

 How long to take:

This medicine can be taken for a period of 6 – 8 weeks as per doctors advice. After that time, usually the dose is gradually reduced and the medicine is stopped in next 6 weeks of time.

 Gufic Sallaki 600/400 MG Tablet Side effects:

  1. There are no recorded side effects with this medicine.
  2. It is usually prescribed in a lower dose during lactation and in children.
  3. Consult your doctor for its usage during pregnancy.
  4. Store in a cool dry place, away from sunlight.

Disclaimer:
Despite our attempts to provide you with the most accurate information possible, the actual packaging, ingredients and colour of the product may sometimes vary. Please read the label, directions and warnings carefully before use.

See more

Product Information

General Information

Brand Gufic Bio
Manufacturer Gufic Bio
Manufacturer Email randhir_singh@colpal.com
Manufacturer Website www.colgate.com
Sold By Pharmayush Retail
Pharmayush
Customer Care Email
contact@pharmayush.com
Pharmayush
Customer Care Phone
8921233346
Country of Origin India
Manufacturer
Address

Product Details

Net Quantity 100 g
See more